Publication | Open Access
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study
20
Citations
24
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1